ϩ channels regulates cytosolic free Ca 2ϩ concentration by controlling membrane potential. A rise in cytosolic free Ca 2ϩ concentration in pulmonary artery smooth muscle cells (PASMC) triggers pulmonary vasoconstriction and stimulates PASMC proliferation. Whether serum from children with pulmonary hypertension (PH) secondary to congenital cardiopulmonary diseases contains a factor(s) that inhibits K ϩ channel function in PASMC was investigated using patch clamp techniques. PASMC isolated from normal subjects were cultured in media containing 5% serum from normotensive (NPH) or PH patients. Cell growth rate and the currents through voltage-gated K ϩ channels were determined and compared between the cells treated with serum from NPH and PH patients. In the absence of growth factors, incubation of PASMC in media containing NPH serum for 48 h increased cell numbers by 2.5-fold, whereas incubation of the cells in media containing PH serum increased cell numbers by 4.5-fold (p Ͻ 0.001). Amplitude of whole-cell voltage-gated K ϩ currents in NPH serum-treated cells (1119 Ϯ 222 pA at ϩ80 mV, n ϭ 43) was 3.5-fold greater than in PH serum-treated cells (323 Ϯ 34 pA, n ϭ 43, p Ͻ 0.001). Consistently, membrane potential was much more depolarized in PASMC treated with PH serum (Ϫ28 Ϯ 2 mV, n ϭ 29) than cells treated with NPH-serum (Ϫ47 Ϯ 2 mV, n ϭ 28; p Ͻ 0.001).
PH contributes significantly to the morbidity and mortality of children with congenital heart defects (1). PH in congenital heart disease may be caused by increased pulmonary blood flow, left-side obstructive lesions, pulmonary vasoconstriction, vascular remodeling, and thrombosis in situ. These causes can be present in isolation or in combination (2) . The most common cardiac defect associated with PH is a ventricular septal defect. If the defect is left open or remains large, many patients develop pulmonary vascular obstructive disease and irreversible PH (3); this phenomenon is called Eisenmenger syndrome. Patients with Eisenmenger syndrome have elevated pulmonary vascular resistance and systemic or suprasystemic PAP (which causes a right-to-left shunt).
The pathophysiology of PH secondary to congenital heart lesions shares several characteristics with PPH; including persistent pulmonary vasoconstriction and significant vascular wall remodeling (mainly because of smooth muscle hypertro-phy and proliferation) (1) . However, the precise cellular mechanisms leading to PH in children with congenital heart defects remain incompletely understood. Recently, we observed that expression and function of Kv channels in PASMC are both attenuated in patients with PPH, suggesting that dysfunction of Kv channels may play an important role in the development of PH in patients with PPH (4, 5) .
Activity of Kv channels regulates resting E m in PASMC (6 -8) . E m , by controlling the function of sarcolemmal voltagegated Ca 2ϩ channels, is a key determinant of [Ca 2ϩ ] cyt and thus pulmonary vascular tone (7, 9, 10) . Inhibition of Kv channels results in membrane depolarization, which opens voltagedependent Ca 2ϩ channels, promotes Ca 2ϩ influx, and increases [Ca 2ϩ ] cyt in PASMC (6 -12) . A rise in [Ca 2ϩ ] cyt has been demonstrated to be a major trigger for vasoconstriction (10) and an important stimulus for cell proliferation (13, 14) . Accordingly, this study was designed to test the hypothesis that the serum from children with PH secondary to congenital heart defects may possess a factor(s) that stimulates cell proliferation by inhibiting K ϩ channel activity in normal PASMC.
METHODS

Serum preparation.
Patients participating in this study were classified into two groups based on hemodynamic data (Table  1) : 1) normotensive control group including children with normal PAP; and 2) PH group including children with a mean PAP Ն 40% of mean systemic arterial pressure. Blood (3-5 mL) was obtained from each patient at the time of cardiac catheterization. The serum was isolated from whole blood and used to perform the proposed experiments. The study was approved by the Human Research Committee of the University of California, San Diego. Informed consent was obtained from all participant patients before blood was drawn.
Cell culture. Human PASMC from normal subjects were purchased from Clonetics (BioWhittaker Inc., Walkersville, MD, U.S.A.) and used at the fourth to sixth passages. The cells, plated onto coverslips (for electrophysiologic experiments) or Petri dishes (for cell counting), were first cultured in SMGM (Clonetics) in a 37°C, 5% CO 2 , humidified incubator for 48 -60 h. The SMGM consisted of SMBM, 5% FBS, 5 g/mL insulin, 2 ng/mL hFGF, and 0.5 ng/mL hEGF (Clonetics). The proliferating PASMC cultured in SMGM were then growtharrested by culturing them in SMBM for 24 -48 h before each experiment.
The purity of PASMC in cultures was confirmed by the specific MAb raised against smooth muscle ␣-actin (Boehringer-Mannheim Biochemicals, Indianapolis, IN, U.S.A.). The cells were stained with the membrane-permeable nucleic acid stain, 4',6'-diamidino-2-phenylindole (DAPI, 5 M; Molecular Probes, Eugene, OR, U.S.A.). All the DAPI-stained cells in the cultures cross-reacted with the smooth muscle cell ␣-actin antibody, indicating that the cultures consisted only of smooth muscle cells. There were no significant morphologic differences in the cells cultured in media with and without serum or growth factors.
Treatment of cells with serum from NPH or PH patients. Quiescent (growth-arrested) PASMC cultured in SMBM were divided into two groups. One group of cells was cultured in SMBM containing 5% serum from NPH patients (with or without the growth factors). The other group was cultured in SMBM containing 5% serum from PH patients (with or without the growth factors). Both groups of cells were incubated in an incubator equilibrated with 5% CO 2 in air. After 48 h, the cell growth rate was determined using a hemocytometer, and whole-cell I K were measured by patch clamp techniques.
Determination of growth rate. Cells attached to Petri dishes were trypsinized and harvested into 10-mL tubes. After 5 min of centrifugation at 15,000 rpm, the cell pellet was resuspended into Hanks' balanced salt solution (Clonetics). Nine microliters of cell suspension was pipetted into one of the counting chambers in a hemocytometer. Viable cell count was determined in each of the four 1-mm 3 corner squares and averaged to calculate total cell number (cells/milliliter) in cell suspension. The normalized cell number by size of the Petri dishes (cells/square centimeter) was used to compare cell growth rate. mPAP, mean pulmonary artery pressure; mSBP, mean systemic blood pressure; Q p /Q s , the ratio of pulmonary blood blow to systemic blood flow; Sv O 2 , mixed venous oxygen saturation; TGA, transposition of the great arteries; VSD, ventricular septal defect; MV, mitral valve; S/P, status post; PA, pulmonary atresia; LV, left ventricle; ASD, atrial septal defect; DORV, double-outlet right ventricle; TOF, tetralogy of Fallot; PDA, patent ductus arteriosus; CoA, coarctation of the aorta; AS, aortic stenosis; TAPVR, total anomalous pulmonary venous return; PS, pulmonary stenosis.
* Hemodynamic measurements not available.
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Cell viability was determined using 0.45% trypan blue (Sigma Chemical Co., St. Louis, MO, U.S.A.). Electrophysiologic measurements. Whole-cell I K were recorded with an Axopatch-1D amplifier and a DigiData 1200 interface (Axon Instruments, Burlingame, CA, U.S.A.) using patch clamp techniques (7, 15) . Patch pipettes (2-4 M⍀) were made on a Sutter electrode puller (Sutler Instrument Co., Novato, CA, U.S.A.) using borosilicate glass tubes and fire polished on a Narishige microforge (Narishige Scientific Instrument Lab, Tokyo, Japan).
Step-pulse protocols and data acquisition were performed using pCLAMP software. Currents were filtered at 1-2 kHz (Ϫ3 dB) and digitized at 2-4 kHz using an Axopatch-1D amplifier. All experiments were performed at room temperature (22-24°C) . E m in single PASMC was measured in current-clamp mode (I ϭ 0) using whole-cell patch clamp techniques.
Reagents and solutions. A coverslip containing the cells was positioned in the recording chamber (approximately 0.75 mL) on a Nikon microscope and superfused (2 mL/min) with the extracellular (bath) PSS for recording I K. The PSS contained (in mM): 141 NaCl, 4. Statistical analysis. The composite data are expressed as mean ϮSEM. Statistical analyses were performed using unpaired t test or ANOVA and post hoc tests (Student-NewmanKeuls) as appropriate. Differences were considered to be significant when p Ͻ 0.05.
RESULTS
Demographic and clinical characteristics of patients.
The sera used for this study were obtained from five NPH patients and three PH patients. The clinical, demographic, and hemodynamic characteristics of the eight subjects are shown in Table 1 . The average mean PAP in PH patients was significantly higher than in NPH patients (50.7 Ϯ 6.4 versus 11.7 Ϯ 2.2 mm Hg, p Ͻ 0.01), whereas the mean systemic arterial pressure was similar (60.3 Ϯ 7.7 versus 64.8 Ϯ 21.9 mm Hg, p ϭ 0.5). Furthermore, the ratio of pulmonary blood flow to systemic blood flow in NPH patients was 1.5 Ϯ 0.7 and in PH patients was 2.8 Ϯ 0.2 (p Ͻ 0.01). These results indicate that the PH patients have high PAP and high pulmonary blood blow.
Enhanced cell proliferation in PASMC treated with serum from PH patients. PASMC were first growth-arrested in media without serum or growth factors. After 24 h, the quiescent PASMC were then cultured in media containing 5% serum from NPH patients or PH patients in the absence or presence of growth factors (i.e. insulin, hFGF, and hEGF) for 48 h. As shown in Figure 1 , increases in cell numbers after 48 h were significantly greater in PASMC cultured in media containing serum from PH patients (from 1820 Ϯ 244 to 9879 Ϯ 1012 cells/cm 2 ) than in cells cultured in media containing serum from NPH patients (from 1820 Ϯ 244 to 6462 Ϯ 494 cells/ cm 2 ). These results indicate that the growth rate in cells treated with PH serum was 1.75-fold greater than in cells treated with NPH serum. Addition of growth factors (e.g. insulin, hFGF, and hEGF) appeared to have little effect on cell growth in PASMC cultured in media containing 5% serum from NPH or PPH patients (Fig. 1) . These observations suggest that the serum from PH patients may include a mitogenic factor that stimulates PASMC growth in the presence or absence of insulin, hFGF, and hEGF.
Reduced whole-cell I K(V) in PASMC treated with serum from PH patients. Whole-cell I K(V) were isolated in PASMC superfused with Ca 2ϩ -free (plus 1 mM EGTA) bath solution and dialyzed with Ca 2ϩ -free (plus 10 mM EGTA) and ATPcontaining pipette solutions. The removal of extracellular and intracellular Ca 2ϩ and inclusion of 5 mM ATP in the pipette solution minimized the contribution of Ca 2ϩ -activated and ATP-sensitive K ϩ currents to the measured currents. Whole-cell I K(V) were elicited by depolarizing the cells from a holding potential of Ϫ70 mV to a series of test potentials ranging from Ϫ80 to ϩ80 mV in increments of 20 mV (Fig.  2A) . The amplitude of the steady-state I K(V) in PASMC was significantly attenuated by incubating the cells in media containing serum from PH patients, in comparison with the cells cultured in media containing serum from NPH patients (Fig. 2,  A and B) . The composite current-voltage relationships (I-V curves) demonstrate that PH serum caused an approximately 71% reduction of whole-cell I K(V) amplitude at ϩ80 mV (from 1119 Ϯ 222 to 323 Ϯ 34 pA, p Ͻ 0.001) and an approximately 81% decrease at Ϫ20 mV (from 40 Ϯ 8 to 8 Ϯ 2 pA, n ϭ 43, p Ͻ 0.001; Fig. 2B ). The averaged currents, elicited by a ϩ80-mV test pulse, show that the activation and inactivation kinetics of the currents were unaltered in PASMC treated with PH serum, in comparison with the cells cultured in media containing NPH serum (Fig. 2C) . The time constants for current activation were 3.4 Ϯ 0.5 and 3.6 Ϯ 0.5 ms (p ϭ 0.73) Figure 1 . Enhancement of PASMC growth by serum from PH patients. Cell numbers were determined using a hemacytometer before (basal) and after treatment of the cells with serum from NPH or PH patients in the absence (ϪGF) or presence (ϩGF) of growth factors (GF). Data are mean ϮSEM with numbers of independent experiments in parentheses. **p Ͻ 0.01, ***p Ͻ 0.001 vs NPH.
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ϩ CHANNEL ACTIVITY and for current inactivation, 125.1 Ϯ 37.3 and 160.7 Ϯ 35.8 ms (p ϭ 0.53) in PASMC treated with NPH or PH serum, respectively (Fig. 2, D and E) .
Consistent with the inhibitory effect on whole-cell I K(V) , the serum from PH patients also caused a significant membrane depolarization in PASMC (Fig. 3) . The average resting E m in PASMC cultured in media containing NPH serum was Ϫ47 Ϯ 2 mV (n ϭ 28), whereas in cells cultured in media containing PH serum it was Ϫ28 Ϯ 2 mV (n ϭ 29, p Ͻ 0.001). These observations indicate that serum from PH patients may contain a K ϩ channel antagonist that blocks Kv channels. The resultant decrease in the amplitude of I K(V) induces membrane depolarization and may thus increase [Ca 2ϩ ] cyt by activating voltagegated Ca 2ϩ channels in PASMC (7, 9 ). These observations demonstrate that, in PASMC treated with serum from PH patients, 1) Kv channel activity was diminished, 2) E m was depolarized, and 3) cell proliferation rate was enhanced, in comparison with cells treated with serum from NPH patients. The next set of experiments was designed to examine whether decreased Kv channel activity and membrane depolarization were involved in human PASMC proliferation by comparing I K(V) and E m in growth-arrested and proliferating PASMC.
Comparison of whole-cell I K(V) and resting E m in growtharrested and proliferating PASMC. Human PASMC were first plated in Petri dishes and cultured in the growth medium, SMGM (containing 5% FBS and growth factors). After 24 h, the cells were divided into two groups and cultured in SMGM (growth medium) and SMBM (basal medium without serum and growth factors) for 48 -60 h. Removal of serum and growth factors from culture medium significantly inhibited human PASMC growth (Fig. 4A) , suggesting that cells cultured in serum-free medium (SMBM) are growth-arrested cells, and cells cultured in serum-and growth factor-containing medium (SMGM) are proliferating cells.
In proliferating PASMC, amplitude of whole-cell I K(V) was significantly reduced, in comparison with growth-arrested cells (Fig. 4, B and C) . Accordingly, resting E m in proliferating PASMC was much more depolarized than in growth-arrested PASMC (Fig. 4D) . In smooth muscle cells, the voltage window of sarcolemmal L-type voltage-gated Ca 2ϩ channels for sus- tained elevation of [Ca 2ϩ ] cyt ranges from Ϫ40 to Ϫ20 mV and peaks at Ϫ30 mV (11) . Thus, the sustained membrane depolarization in proliferating PASMC may produce a constant Ca 2ϩ influx through L-type voltage-gated Ca 2ϩ channels, and contribute to initiating and maintaining the elevated [Ca 2ϩ ] cyt crucial for cell proliferation (7, 9, 11, 14) .
DISCUSSION
The precise cellular mechanisms responsible for the elevated pulmonary vascular resistance and arterial pressure in patients with congenital cardiopulmonary diseases remain incompletely understood. An increased circulating factor that induces pulmonary vasoconstriction and stimulates PASMC and endothelial cell growth has been implicated in patients with PH (16 -20) . The observations from this study demonstrated that the serum from PH patients 1) significantly enhanced normal PASMC proliferation in the absence or presence of growth factors, 2) markedly decreased the amplitude of whole-cell I K(V) , and 3) significantly depolarized E m in PASMC. Furthermore, I K(V) was greatly decreased and E m was significantly depolarized in proliferating cells compared with growtharrested cells, indicating a close linkage between membrane depolarization (owing to decreased K ϩ channel activity) and cell proliferation in human PASMC (14) .
Serum from patients with PH secondary to congenital heart defects may contain 1) a vasoactive agonist that inhibits Kv channels, induces E m depolarization, opens voltage-dependent Ca 2ϩ channels, increases [Ca 2ϩ ] cyt , and eventually stimulates cell growth; 2) a mitogenic agonist that stimulates cell growth by activating a Kv channel-independent pathway; and 3) both vasoactive and mitogenic agonists. The mitogenic agonist(s) or Kv channel blocker(s) may be produced sporadically as a result of high blood flow and arterial pressure (e.g. shear stressmediated endothelium injury) (21) (22) (23) . Another possibility is that the existing mitogenic agonists in serum are up-regulated in patients with PH secondary to congenital cardiopulmonary diseases.
Shear stress, caused by hyperkinetic pulmonary circulation in patients with PH secondary to congenital heart defects, may cause endothelial injury and lead to release of a variety of vasoconstrictor agonists, e.g. endothelium-derived constricting factors (23) , cytokines (e.g. interleukins, leukotrienes) (16) , and serotonin (17) . Shear stress-mediated gene expression of growth factors (e.g. VEGF) in endothelial cells and their release to the pulmonary circulation (24) may also contribute to mediating pulmonary vasoconstriction and vascular remodeling in patients with PH. Stretch of the pulmonary vessels, owing to high blood flow and arterial pressure, increases activity of stretch-activated cation channels and facilitates synthesis and release of vasoactive substances and mitogenic agonists by raising [Ca 2ϩ ] cyt in vascular smooth muscle and endothelial cells. Furthermore, the hypoxemia and ischemia caused by congenital heart defects, e.g. Eisenmenger syndrome, may also facilitate release and production of vasoactive and mitogenic agonists (e.g. norepinephrine, epinephrine, serotonin, VEGF).
A variety of vasoactive and mitogenic substances are present in the serum of children with PH secondary to congenital heart disease (1, 3, 20, 24) . Increased blood levels of endothelin-1 (an endothelium-derived constricting factor) (18 -22) , VEGF (24) , serotonin (17) , and angiopoietin (25) have been implicated in the development of PH. Up-regulated gene expression of angiopoietin and its release to the blood from cardiac myocytes may also contribute to the pulmonary vascular remodeling in patients with PH secondary to congenital heart defects [(25); also Dr. P.A. Thistlethwaite, personal communication]. The results from the current study imply that the up-regulated mitogenic substances (e.g. endothelin-1) in pa- 
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ϩ CHANNEL ACTIVITY tients with congenital heart diseases may stimulate PASMC proliferation by, at least partially, attenuating Kv channel activity in PASMC. The observations shown in Figure 2 indicate that serum from PH patients only decreased the amplitude of I K(V) with no effect on the kinetics of channel activation and inactivation. The amplitude of whole-cell I K(V) is proportional to the number of functional Kv channels expressed in the plasma membrane and the amplitude of the unitary current (which is determined by the single-channel conductance and the steady-state open probability of the Kv channel). Therefore, the cellular mechanisms responsible for the inhibitory effect of PH serum on whole-cell I K(V) may likely result from down-regulation of gene expression of Kv channel ␣ subunits, the pore-forming subunits, and decrease in I K(V) availability. The resultant membrane depolarization promotes Ca 2ϩ influx by opening voltagedependent Ca 2ϩ channels, a major pathway for Ca 2ϩ influx in vascular smooth muscle cells (9, 11) . A rise in [Ca 2ϩ ] cyt , which rapidly increases nuclear [Ca 2ϩ ] (within 200 ms) (26) and gradually increases the intracellularly stored [Ca 2ϩ ] in the sarcoplasmic reticulum (27) , can 1) activate mitogen-activated protein (MAP) kinase cascade that stimulates synthesis of transcription factors required for cell proliferation, and 2) promote cell proliferation by moving quiescent cells into the cell cycle and by propelling the proliferating cells through mitosis (28 -31) .
In summary, the results from this study suggest that a circulating Kv channel blocker may be produced or a mitogenic agonist existing in serum may be up-regulated in patients with PH secondary to congenital cardiopulmonary diseases. The agonist-mediated inhibition of Kv channels in PASMC induces membrane depolarization, which may increase [Ca 2ϩ ] cyt by opening L-type voltage-dependent Ca 2ϩ channels. The increase in [Ca 2ϩ ] cyt in PASMC then triggers cell contraction by activating calmodulin and stimulates cell proliferation by accelerating the progression of the cell cycle. The resultant pulmonary vasoconstriction and vascular medial hypertrophy ultimately contribute to increase pulmonary vascular resistance and arterial pressure.
